Medikamentöse Therapieansätze zur Behandlung der männlichen Infertilität
暂无分享,去创建一个
[1] H. Behre,et al. Tamoxifen bei männlicher Infertilität*: Analyse einer fragwürdigen Therapie , 2008 .
[2] C. Farquhar,et al. Gonadotrophins for idiopathic male factor subfertility. , 2007, The Cochrane database of systematic reviews.
[3] A. Barlier,et al. Quinagolide--a valuable treatment option for hyperprolactinaemia. , 2006, European journal of endocrinology.
[4] L. Rienzi,et al. ICSI in cases of sperm DNA damage: beneficial effect of oral antioxidant treatment. , 2006, Human reproduction.
[5] G. Haidl,et al. Role of granulocyte elastase and interleukin‐6 in the diagnosis of male genital tract inflammation , 2005, Andrologia.
[6] E. Koukkou,et al. Responsiveness to tamoxifen citrate and testosterone undecanoate is independent of the severity of idiopathic oligozoospermia. , 2005, Journal of Andrology.
[7] J. Alvarez. 'Efficient treatment of infertility due to sperm DNA damage by ICSI with testicular sperm'. , 2005, Human Reproduction.
[8] G. Delitala,et al. Successful treatment of retrograde ejaculation with the α1-adrenergic agonist methoxamine: case study , 2005, International journal of impotence research.
[9] G. Block,et al. Antioxidant intake is associated with semen quality in healthy men. , 2005, Human reproduction.
[10] G. Bartsch,et al. Neoadjuvant gonadotropin-releasing hormone therapy before surgery may improve the fertility index in undescended testes: a prospective randomized trial. , 2005, The Journal of urology.
[11] C. Giorgetti,et al. Crude cumulative delivery rate following ICSI using intentionally frozen-thawed testicular spermatozoa in 51 men with non-obstructive azoospermia. , 2005, Reproductive biomedicine online.
[12] A. Colao,et al. PRL Secreting Adenomas in Male Patients , 2005, Pituitary.
[13] D. Rees,et al. Azoospermia in testicular sarcoidosis is an indication for corticosteroid therapy. , 2004, Fertility and sterility.
[14] A. El‐Tawil. Zinc deficiency in men with Crohn's disease may contribute to poor sperm function and male infertility , 2003, Andrologia.
[15] E. Koukkou,et al. Effectiveness of combined tamoxifen citrate and testosterone undecanoate treatment in men with idiopathic oligozoospermia. , 2003, Fertility and sterility.
[16] A. Lenzi,et al. Use of carnitine therapy in selected cases of male factor infertility: a double-blind crossover trial. , 2003, Fertility and sterility.
[17] M. Välimäki,et al. Primary infertility in 45-year-old man with untreated 21-hydroxylase deficiency: successful outcome with glucocorticoid therapy. , 2002, The Journal of clinical endocrinology and metabolism.
[18] G. Zielhuis,et al. Effects of folic acid and zinc sulfate on male factor subfertility: a double-blind, randomized, placebo-controlled trial. , 2002, Fertility and sterility.
[19] P. Schlegel,et al. Aromatase inhibitors for male infertility. , 2002, The Journal of urology.
[20] T. Strowitzki,et al. Are zinc levels in seminal plasma associated with seminal leukocytes and other determinants of semen quality? , 2002, Fertility and sterility.
[21] E. Brähler,et al. Zur Epidemiologie gewollter und ungewollter Kinderlosigkeit in Ost- und Westdeutschland , 2001 .
[22] W. Dhooge,et al. The effects of combined conventional treatment, oral antioxidants and essential fatty acids on sperm biology in subfertile men. , 2000, Prostaglandins, leukotrienes, and essential fatty acids.
[23] G. Haidl,et al. Drug treatment of male fertility disorders. , 2000, Asian Journal of Andrology.
[24] M. Plebani,et al. FSH in the treatment of oligozoospermia , 2000, Molecular and Cellular Endocrinology.
[25] R. Lilford,et al. Kinin-enhancing drugs for unexplained subfertility in men. , 1996, The Cochrane database of systematic reviews.
[26] R. Lilford,et al. Clomiphene or tamoxifen for idiopathic oligo/asthenospermia. , 1996, The Cochrane database of systematic reviews.
[27] Z. Rokyta,et al. Effect of corticosteroids on sperm antibody concentration in different biological fluids and on pregnancy outcome in immunologic infertility. , 2000, Zentralblatt fur Gynakologie.
[28] J. Jarow. Follicle-stimulating hormone treatment for men with idiopathic oligoteratoasthenozoospermia before in vitro fertilization: the impact on sperm microstructure and fertilization potential. , 2000, The Journal of urology.
[29] G. Haidl. Which efforts towards conservative treatment of male infertility will be successful? Mast cell blockers , 1999, Andrologia.
[30] Z. Ben-Rafael,et al. The role of purified follicle stimulating hormone therapy in the male partner before intracytoplasmic sperm injection. , 1999, Fertility and sterility.
[31] E. Nieschlag,et al. Antioxidant treatment of patients with asthenozoospermia or moderate oligoasthenozoospermia with high-dose vitamin C and vitamin E: a randomized, placebo-controlled, double-blind study. , 1999, Human reproduction.
[32] H. Dashti,et al. Treatment of asthenozoospermia with zinc sulphate: andrological, immunological and obstetric outcome. , 1998, European journal of obstetrics, gynecology, and reproductive biology.
[33] V. McKelvey-Martin,et al. The effects of antioxidant supplementation during Percoll preparation on human sperm DNA integrity. , 1998, Human reproduction.
[34] C. Foresta,et al. Evidence for a stimulatory role of follicle-stimulating hormone on the spermatogonial population in adult males. , 1998, Fertility and sterility.
[35] J. Kratzsch,et al. Effects of pure human follicle‐stimulating hormone (pFSH) on sperm quality correlate with the hypophyseal response to gonadotrophin‐releasing hormone (GnRH) * , 2009, Andrologia.
[36] B. Corcóstegui,et al. Treatment of the male with follicle-stimulating hormone in intrauterine insemination with husband's spermatozoa: a randomized study. , 1998, Human reproduction.
[37] S. Savastano,et al. Success of glucocorticoid replacement therapy on fertility in two adult males with 21-CAH homozygote classic form , 1997, Journal of endocrinological investigation.
[38] S. Suleiman,et al. Lipid peroxidation and human sperm motility: protective role of vitamin E. , 1996, Journal of andrology.
[39] E. Fabbri,et al. Effectiveness of pentoxifylline in semen preparation for intrauterine insemination. , 1996, Human reproduction.
[40] D. Irvine,et al. Glutathione as a treatment for male infertility. , 1996, Reviews of reproduction.
[41] E. Nieschlag,et al. [Tamoxifen in male infertility. Analysis of a questionable therapy]. , 1996, Deutsche Medizinische Wochenschrift.
[42] E. Nieschlag,et al. Recombinant human follicle-stimulating hormone and human chorionic gonadotropin for induction of spermatogenesis in a hypogonadotropic male , 1998 .
[43] K. Miyake,et al. New treatment of idiopathic severe oligozoospermia with mast cell blocker: results of a single-blind study. , 1995, Fertility and sterility.
[44] Z. Nagy,et al. Andrology: Results of 55 intracytoplasmic sperm injection cycles in the treatment of male-immunological infertility , 1995 .
[45] E. Nieschlag,et al. Recombinant human follicle-stimulating hormone**Study medication was supplied by Organon International, Oss, The Netherlands. and human chorionic gonadotropin for induction of spermatogenesis in a hypogonadotropic male††Supported by the Deutsche Forschungsgemeinschaft, Bonn, Germany (Ni 130/11). , 1995 .
[46] G. Vitali,et al. Carnitine supplementation in human idiopathic asthenospermia: clinical results. , 1995, Drugs under experimental and clinical research.
[47] A. Lenzi,et al. L‐ carnitine in idiopathic asthenozoospermia: a multicenter study , 2009, Andrologia.
[48] S. Passi,et al. Andrology: Glutathione treatment of dyspermia: effect on the lipoperoxidation process , 1994 .
[49] E. Nieschlag,et al. Ineffectiveness of kallikrein in treatment of idiopathic male infertility: a double-blind, randomized, placebo-controlled trial. , 1994, Human reproduction.
[50] A. Lenzi,et al. Placebo-controlled, double-blind, cross-over trial of glutathione therapy in male infertility. , 1993, Human reproduction.
[51] J. Tesarik,et al. Sperm treatment with pentoxifylline improves the fertilizing ability in patients with acrosome reaction insufficiency , 1993, Fertility and sterility.
[52] V. Kay,et al. Pentoxifylline stimulates hyperactivation in human spermatozoa. , 1993, Human reproduction.
[53] S. Oehninger,et al. Pure human follicle stimulating hormone has a role in the treatment of severe male infertility by assisted reproduction: Norfolk's total experience. , 1992, Human reproduction.
[54] W. Krause,et al. Treatment of idiopathic oligozoospermia with tamoxifen--a randomized controlled study. , 1992, International journal of andrology.
[55] E. Tsai,et al. Effects of pentoxifylline in the hamster zona-free oocyte spermatozoa penetration assay and on spermatozoa transmembrane migration motility. , 1992, European Urology.
[56] A. Lenzi,et al. Glutathione therapy for male infertility. , 1992, Archives of andrology.
[57] A. Spira,et al. Incidence and main causes of infertility in a resident population (1,850,000) of three French regions (1988-1989). , 1991, Human reproduction.
[58] C. Y. Hong,et al. Pentoxifylline stimulates human sperm motility both in vitro and after oral therapy. , 1991, British journal of clinical pharmacology.
[59] R. V. Clark,et al. Treatment of men with idiopathic oligozoospermic infertility using the aromatase inhibitor, testolactone. Results of a double-blinded, randomized, placebo-controlled trial with crossover. , 1989, Journal of andrology.
[60] WORLD HEALTH ORGANIZATION TASK FORC Infertility. Mesterolone and idiopathic male infertility: a double-blind study. World Health Organization Task Force on the Diagnosis and Treatment of Infertility. , 1989, International Journal of Andrology.
[61] A. Desmond,et al. Changes in Seminal Quality Following Oral Zinc Therapy , 2009, Andrologia.
[62] L. Björndahl,et al. Sperm nuclear zinc, chromatin stability, and male fertility. , 1987, Scanning microscopy.
[63] H. Korting,et al. [Long-term therapy of oligozoospermia with the aromatase inhibitor testolactone]. , 1987, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.
[64] J. Ring,et al. The Use of Ketotifen, a Mast Cell Blocker, for Treatment of Oligo‐ and Asthenozoospermia * , 2009, Andrologia.
[65] W. Krause,et al. Treatment of Oligozoospermia by Tamoxifen: No Evidence for Direct Testicular Action , 2009, Andrologia.
[66] P. Marrama,et al. Further Studies on the Effects of Pentoxifylline on Sperm Count and Sperm Motility in Patients with Idiopathic Oligo‐Asthenozoospermia , 2009, Andrologia.
[67] Robert C. Wolpert,et al. A Review of the , 1985 .
[68] H. Zuckerman,et al. The prostaglandin inhibitor effect of antiinflammatory drugs in the therapy of male infertility. , 1984, Fertility and sterility.
[69] C. W. Chan,et al. Comparison of the effectiveness of placebo, clomiphene citrate, mesterolone, pentoxifylline, and testosterone rebound therapy for the treatment of idiopathic oligospermia. , 1983, Fertility and sterility.
[70] Schill Wb. [Therapy of idiopathic astheno- and oligozoospermia with pentoxifylline]. , 1982 .
[71] W. Schill. [Therapy of idiopathic astheno- and oligozoospermia with pentoxifylline]. , 1982, Fortschritte der Medizin.
[72] K. Yamada,et al. Mastocytosis occurring in the testes from patients with idiopathic male infertility. , 1981, Fertility and sterility.
[73] L. Schwarzstein,et al. Pentoxifylline (BL 191) by Oral Administration in the Treatment of Asthenozoospermia , 2009, Andrologia.
[74] W. Schill. Treatment of idiopathic oligozoospermia by kallikrein: results of a double-blind study. , 1979, Archives of andrology.
[75] D. London,et al. Hormonal effects of tamoxifen in oligospermic men. , 1977, The Journal of endocrinology.
[76] J. Marmar,et al. Semen zinc levels in infertile and postvasectomy patients and patients with prostatitis. , 1975, Fertility and sterility.
[77] A. Klopper,et al. ANTIOESTROGENS: A REVIEW , 1975, Clinical endocrinology.